WO2008078726A1 - 固形製剤 - Google Patents
固形製剤 Download PDFInfo
- Publication number
- WO2008078726A1 WO2008078726A1 PCT/JP2007/074781 JP2007074781W WO2008078726A1 WO 2008078726 A1 WO2008078726 A1 WO 2008078726A1 JP 2007074781 W JP2007074781 W JP 2007074781W WO 2008078726 A1 WO2008078726 A1 WO 2008078726A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- solid preparation
- azelnidipine
- olmesartan medoxomil
- disclosed
- contact
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008551104A JP5241510B2 (ja) | 2006-12-26 | 2007-12-25 | 固形製剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006-349475 | 2006-12-26 | ||
JP2006349475 | 2006-12-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008078726A1 true WO2008078726A1 (ja) | 2008-07-03 |
Family
ID=39562515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2007/074781 WO2008078726A1 (ja) | 2006-12-26 | 2007-12-25 | 固形製剤 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5241510B2 (ko) |
KR (1) | KR20090094288A (ko) |
TW (1) | TWI402083B (ko) |
WO (1) | WO2008078726A1 (ko) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010107081A1 (ja) * | 2009-03-19 | 2010-09-23 | 第一三共株式会社 | 包装により安定保存された固形製剤 |
JP2011225537A (ja) * | 2010-03-31 | 2011-11-10 | Daiichi Sankyo Co Ltd | 固形製剤の製造方法 |
JP2012532118A (ja) * | 2009-06-30 | 2012-12-13 | サノフイ | イルベサルタンおよびアムロジピンを含む固体医薬固定用量組成物、これらの調製ならびにこれらの治療用途 |
JP2013023452A (ja) * | 2011-07-15 | 2013-02-04 | Nipro Corp | カルシウムブロッカーを含有する固形医薬組成物 |
CN103239418A (zh) * | 2013-05-29 | 2013-08-14 | 南京正大天晴制药有限公司 | 一种阿折地平片剂及其制备方法 |
JP5897196B1 (ja) * | 2015-10-05 | 2016-03-30 | 大同化成工業株式会社 | 糖又は糖アルコール、膨潤型結合剤、崩壊剤及び高吸収性賦形剤を含む複合化造粒物及びその製造方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004067003A1 (ja) * | 2003-01-31 | 2004-08-12 | Sankyo Company, Limited | 動脈硬化及び高血圧症の予防及び治療のための医薬 |
JP2006298764A (ja) * | 2005-04-15 | 2006-11-02 | Sankyo Co Ltd | 高血圧症治療に有用な複合体 |
WO2007001067A2 (en) * | 2005-06-27 | 2007-01-04 | Daiichi Sankyo Company, Limited | Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130135994A (ko) * | 2005-06-27 | 2013-12-11 | 다이이찌 산쿄 가부시키가이샤 | 안지오텐신 ⅱ 수용체 길항제 및 칼슘 채널 차단제를 함유한 약학 제제 |
TWI407978B (zh) * | 2005-06-27 | 2013-09-11 | Sankyo Co | 濕粒狀藥物之製備方法 |
-
2007
- 2007-12-24 TW TW096149679A patent/TWI402083B/zh not_active IP Right Cessation
- 2007-12-25 JP JP2008551104A patent/JP5241510B2/ja active Active
- 2007-12-25 WO PCT/JP2007/074781 patent/WO2008078726A1/ja active Application Filing
- 2007-12-25 KR KR1020097012661A patent/KR20090094288A/ko not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004067003A1 (ja) * | 2003-01-31 | 2004-08-12 | Sankyo Company, Limited | 動脈硬化及び高血圧症の予防及び治療のための医薬 |
JP2006298764A (ja) * | 2005-04-15 | 2006-11-02 | Sankyo Co Ltd | 高血圧症治療に有用な複合体 |
WO2007001067A2 (en) * | 2005-06-27 | 2007-01-04 | Daiichi Sankyo Company, Limited | Solid dosage form comprising an angiotensin ii receptor antagonist and a calcium channel blocker |
Non-Patent Citations (2)
Title |
---|
MATSUMOTO M.: "Yakuzaigaku Manual", vol. 1ST ED., 1989, NANZANDO CO., LTD., pages: 114 * |
OKANO T.: "Shin.Yakuzaigaku Soron", vol. 3RD ED., 1987, NANKODO CO., LTD. HAKKO, pages: 134 - 145 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6081058B2 (ja) * | 2009-03-19 | 2017-02-15 | 第一三共株式会社 | 包装により安定保存された固形製剤 |
JPWO2010107081A1 (ja) * | 2009-03-19 | 2012-09-20 | 第一三共株式会社 | 包装により安定保存された固形製剤 |
JP2014139256A (ja) * | 2009-03-19 | 2014-07-31 | Daiichi Sankyo Co Ltd | 包装により安定保存された固形製剤 |
WO2010107081A1 (ja) * | 2009-03-19 | 2010-09-23 | 第一三共株式会社 | 包装により安定保存された固形製剤 |
JP2012532118A (ja) * | 2009-06-30 | 2012-12-13 | サノフイ | イルベサルタンおよびアムロジピンを含む固体医薬固定用量組成物、これらの調製ならびにこれらの治療用途 |
JP2011225537A (ja) * | 2010-03-31 | 2011-11-10 | Daiichi Sankyo Co Ltd | 固形製剤の製造方法 |
JP2013023452A (ja) * | 2011-07-15 | 2013-02-04 | Nipro Corp | カルシウムブロッカーを含有する固形医薬組成物 |
CN103239418A (zh) * | 2013-05-29 | 2013-08-14 | 南京正大天晴制药有限公司 | 一种阿折地平片剂及其制备方法 |
CN103239418B (zh) * | 2013-05-29 | 2014-09-03 | 南京正大天晴制药有限公司 | 一种阿折地平片剂及其制备方法 |
JP5897196B1 (ja) * | 2015-10-05 | 2016-03-30 | 大同化成工業株式会社 | 糖又は糖アルコール、膨潤型結合剤、崩壊剤及び高吸収性賦形剤を含む複合化造粒物及びその製造方法 |
WO2017061426A1 (ja) * | 2015-10-05 | 2017-04-13 | 大同化成工業株式会社 | 糖又は糖アルコール、膨潤型結合剤、崩壊剤及び高吸収性賦形剤を含む複合化造粒物及びその製造方法 |
JP2017071561A (ja) * | 2015-10-05 | 2017-04-13 | 大同化成工業株式会社 | 糖又は糖アルコール、膨潤型結合剤、崩壊剤及び高吸収性賦形剤を含む複合化造粒物及びその製造方法 |
US10632074B2 (en) | 2015-10-05 | 2020-04-28 | Daido Chemical Corporation | Composite granulated product including sugar or sugar alcohol, swelling binder, disintegrating agent and highly absorbent excipient, and method for manufacturing composite granulated product |
Also Published As
Publication number | Publication date |
---|---|
KR20090094288A (ko) | 2009-09-04 |
JP5241510B2 (ja) | 2013-07-17 |
TW200835526A (en) | 2008-09-01 |
TWI402083B (zh) | 2013-07-21 |
JPWO2008078726A1 (ja) | 2010-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1999811B8 (en) | Fuel cells | |
GB2434691B8 (en) | Fuel cell. | |
GB0614338D0 (en) | Fuel cells | |
GB0608079D0 (en) | Fuel cells | |
EP2061948B8 (en) | Capillary injector | |
GB0614337D0 (en) | Fuel Cells | |
AU2007205298A8 (en) | Drug combinations | |
WO2008078726A1 (ja) | 固形製剤 | |
WO2008078729A1 (ja) | 溶出性改善方法 | |
AU2006901034A0 (en) | Improvements in piles | |
WO2011066484A9 (en) | Isoxazoline compounds in type 2 diabetes and other maladies | |
AU2006902635A0 (en) | Improvements in engine utilization | |
AU2006906313A0 (en) | Improvements in coffee production. | |
AU2006902300A0 (en) | Improvements in footwear | |
AU2006903771A0 (en) | Improvements in Spacer Type Materials | |
AU2007306595B2 (en) | Authenticity feature in the form of luminescent substances | |
AU2006902899A0 (en) | Changed cells | |
AU2007904137A0 (en) | Gaming machine with two-stage feature determination | |
AU2007101262A4 (en) | Improvements in cots | |
AU3442P (en) | With Love Lavandula hybrid | |
AU2007902603A0 (en) | Improvements in engine utilization | |
GB0619078D0 (en) | Improvements in pizza preparation | |
AU2006901394A0 (en) | Electrochemical sensor | |
WO2009073173A9 (en) | Anti-malpractice in seu | |
AU2006901553A0 (en) | Improvements in Locks |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07860010 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008551104 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097012661 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07860010 Country of ref document: EP Kind code of ref document: A1 |